-+ 0.00%
-+ 0.00%
-+ 0.00%

ROCKET PHARMACEUTICALS, INC. : LEERINK PARTNERS CUTS TARGET PRICE TO $4 FROM $7

Reuters·10/07/2026 02:48:34

Please log in to view news